# Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk

> **NCT05369585** · NA · COMPLETED · sponsor: **Valbiotis** · enrollment: 20 (actual)

## Conditions studied

- Prediabetic State
- Dysglycemia
- Overweight and Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** TOTUM-63

## Key facts

- **NCT ID:** NCT05369585
- **Lead sponsor:** Valbiotis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-25
- **Primary completion:** 2023-04-12
- **Final completion:** 2023-04-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-11-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05369585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05369585, "Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05369585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*